Abstract
Some children have visual disturbances that occur in the absence of, or are out of proportion to, their objective ophthalmological findings. These symptoms reflect a wide range of processes that may be benign or a sign of neurological, systemic, or psychiatric disease. This chapter deals with the neuro-ophthalmologic detection of organic and psychogenic disorders that may manifest as transient or unexplained visual loss, along with other episodic visual disturbances that occur in childhood. In these cases, several formidable problems confront the physician who is trying to reach the correct diagnosis. The descriptions of episodic visual disturbances and hallucinations in children are generally less complex in detail than those in the adult population because children have a limited vocabulary and a limited experiential basis of sensory phenomena to draw upon.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abraham HD. Visual phenomenology of the LSD flashback. Arch Gen Psychiatry. 1983;40:884–9.
Abu-Arafeh I, Callaghan M. Short migraine attacks of less than 2 h duration in children and adolescents. Cephalalgia. 2004;24:333–8.
Abu-Arafeh I, Russell G. Prevalence of headache in schoolchildren. Br Med J. 1994;309:765–9.
Adcock JE, Panayiotopoulos CP. Occipital lobe seizures and epilepsies. J Clin Neurophysiol. 2012;29:397–407.
Afridi SK, Giffin NJ, Kaube H, et al. A positron emission tomography study in spontaneous migraine. Arch Neurol. 2005;62:1270–5.
Afridi SK, Matharu MS, Lee L, et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain. 2005;128:932–9.
Ahn SJ, Ahn J, Park KH, Woo SJ. Multimodal imaging of occult macular dystrophy. JAMA Ophthalmol. 2013;131:880–90.
Aicardi J. Diseases of the Nervous System in Childhood. 2nd ed. London: Mackeith Press; 1998.
Aicardi J, Bourgeois M, Goutieres F. Alternating hemiplegia of childhood: clinical findings and diagnostic criteria. In: Andermann F, Aicardi J, Vigevano F, editors. Alternating Hemiplegia of Childhood. New York: Raven Press; 1995. p. 3–18.
Airy H. On a distinct form of transient hemiopsia. Philos Trans R Soc Lond B Biol Sci. 1870;160:247–64.
Akin R, Ünay B, Sarici SU, Ulaş U, Gökçay. Evaluation of visual evoked potentials in children with headache. Turk J Pediatr. 2005;47:150–2.
Aldrich MS, Vanderzant CW, Alessi AG, Abou-Khalil B, Sackellares JC. Ictal cortical blindness with permanent visual loss. Epilepsia. 1989;30:116–20.
Alvarez WC. The migrainous scotoma as studied in 618 persons. Am J Ophthalmol. 1960;49:489–504.
Ambrosini A, D’Onofrio M, Grieco GS, et al. Familiar basilar migraine associated with a new mutation in the ATPA2 gene. Neurology. 2005;65:1826–8.
American Council on Headache Education with Lynne M. Constantine and Suzanne Scott. Migraine: The Complete Guide: A Comprehensive Resource Book for People with Migraine, Their Families, and Physicians. New York: Dell Publishing; 1994. p. 51.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed (rev). Washington, DC: American Psychiatric Association; 2015.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
Amery WK, Waelkens J, Vandenbergh V. The sensorium of the migraineur. Ital J Neurol Sci. 1988;9:539–45.
Andermann FA. Migraine and epilepsy: an overview. In: Andermann FA, Lugaresi E, editors. Migraine and Epilepsy. Boston: Butterworths; 1987. p. 281–91.
Andersson KE, Vinge E. Beta-adrenoreceptor blockers and calcium antagonists in the prophylaxis and treatment of migraine. Drugs. 1990;39:355–73.
Appleton R, Farrell K, Buncic JR, Hill A. Amaurosis fugax in teenagers: a migraine variant. Am J Dis Child. 1988;142:331–3.
Arffa RC. Grayson’s Diseases of the Cornea. 3rd ed. St Louis: C.V. Mosby; 1991. p. 401–16.
Arruda MA, Bigal ME. Migraine and migraine subtypes in preadolescent children: association with school performance. Neurology. 2012;79:1881–8.
Artman M, Grayson M, Boerth RC. Propranolol in children: safety-toxicity. Pediatrics. 1982;70:30–1.
Aschwanden C. Experts question placebo pill for children. New York Times; May 27; 2008; D5, D7.
Asghar SJ, Milesi-Hallé A, Kaushik C, Glasier C, Sharp GB. Variable manifestations of familial hemiplegic migraine associated with reversible cerebral edema in children. Pediatr Neurol. 2012;47:201–4.
Ashkenazi S, Bellah G, Cleary TG. Hallucinations as an initial manifestation of shigellosis. J Pediatr. 1989;114:95–6.
Aziz HA, Kheir WJ, Young RC, et al. Acute macular neuroretinopathy: a case report and review of the literature 2002-2012. Ophthalmic Surg Lasers Imaging Retina. 2015;46:112–4.
Bahn CA. The psychoneurotic factor in ophthalmic practice. Am J Ophthalmol. 1943;26:369–78.
Bahra A, Matharu MS, Buchel C, Frackowiak RSJ, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet. 2001;357:1016–7.
Bailey B, McManus BC. Treatment of children with migraine in the emergency department: a qualitative systematic review. Pediatr Emerg Care. 2008;24:321–30.
Bain KE, Beatty S, Lloyd C. Non-organic visual loss in children. Eye (Lond). 2000;14:700–2.
Barabas G, Matthews WS, Ferrari M. Childhood migraine and motion sickness. Pediatrics. 1983;72:188–90.
Barkley G, Ramadan NM. The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin. 1990;8:817–28.
Barlow CF. Headaches and Migraine in Childhood. Oxford: Blackwell Scientific; 1984.
Barlow CF. Migraine in the infant and toddler. J Child Neurol. 1994;9:92–4.
Barsook D, May A, Goadsby PJ, Hargreaves R. The Migraine Brain: Imaging Structure and Function. New York: Oxford University Press; 2012.
Basser LS. Benign paroxysmal vertigo of childhood (a variant of vestibular neuronitis). Brain. 1964;87:141–52.
Basser LS. The relation of migraine and epilepsy. Brain. 1969;92:258–300.
Bender MB, Feldman M, Sobin AJ. Palinopsia. Brain. 1968;91:321–38.
Benedik MP, Zaletel M, Meglič NP, et al. Patent foramen ovale and unexplained ischemic cerebrovascular events in children. Catheter Cardiovasc Interv. 2007;70:999–1007.
Berman RJ. Psychogenic visual disorders in an abused child: a case report. Am J Optom Physiol Opt. 1978;55:735–8.
Bernard GA, Bennett JL. Vasospastic amaurosis fugax. Arch Ophthalmol. 1999;117:1568–9.
Besch D, Kurtenbach A, Apfelstedt-Sylla E, et al. Visual field constriction and electrophysiological changes associated with vigabatrin. Doc Ophthalmol. 2002;104:151–70.
Bickerstaff ER. Impairment of consciousness in migraine. Lancet. 1961;2:1057–9.
Bien CG, Benninger FO, Urbach H, Schramm J, Kurthen M, Elger CE. Localizing value of epileptic visual auras. Brain. 2000;123:244–53.
Bigley GK, Sharp FR. Reversible alexia without agraphia due to migraine. Arch Neurol. 1983;40:114–5.
Bille B. Migraine in school children. Acta Paediatr Scand. 1962;51 Suppl 36:1–151.
Bille B, Ludvigsson J, Sanner G. Prophylaxis of migraine in children. Headache. 1977;17:61–3.
Biller J, Johnson MR, Adams HP, et al. Further observations on cerebral or retinal ischemia in patients with right-to-left intracardiac shunts. Arch Neurol. 1987;44:740–3.
Birnbach CD, Järveläinen M, Possin DE, Milam AH. Histopathology and immunocytochemistry of the neurosensory retina in fundus flavimaculatus. Ophthalmology. 1994;101:1211–9.
Binalsheikh IM, Griesemer D, Wang S, Alvarez-Altalef R. Lyme neuroborreliosis presenting as Alice in Wonderland syndrome. Pediatr Neurol. 2012;46:185–6.
Bourke RD, Gole GA. Detection of functional vision loss using the Ishihara plates. Aust N Z J Ophthalmol. 1994;22:115–8.
Boz PJ, Deutman AF. Acute macular neuroretinopathy. Am J Ophthalmol. 1975;80:573–84.
Brandt T. A chameleon among the episodic vertigo syndromes: ‘migrainous vertigo’ or ‘vestibular migraine’. Cephalalgia. 2004;24:81–2.
Brennan KC. Turn down the lights! An irritable occipital cortex in migraine without aura. Neurology. 2011;76:206–7.
Brighina F, Cosentino G, Fierro B. Brain stimulation in migraine. Handb Clin Neurol. 2013;116:585–98.
Brigo F, Storti M, Nardone R, et al. Transcranial magnetic stimulation of the visual cortex in migraine patients: a systematic review with metaanalysis. J Headache Pain. 2012;13:339–49.
Brodsky MC. Contractile morning glory disc causing transient monocular blindness in a child. Arch Ophthalmol. 2006;124:1199–201.
Brodsky MC, Liu GT. The twists and turns of optic disc swelling in a teenager. Surv Ophthalmol. 2013;58:273–7.
Bruen R, Peng SL, Perreault S, Major P, Ospina LH. Persistent migraine aura in an adolescent girl. J AAPOS. 2013;17:426–7.
Brust JC, Behrens MM. “Release hallucinations” as the major symptom of posterior cerebral artery occlusion: a report of 2 cases. Ann Neurol. 1977;2:432–6.
Burch EP. Psychoneurotic reaction patterns in ophthalmology. Trans Am Ophthalmol Soc. 1950;48:370–94.
Burger SK, Saul RF, Selhorst JB, Thurston SE. Transient monocular blindness caused by vasospasm. N Engl J Med. 1991;325:870–3.
Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack: clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000;123:1703–9.
Byrd RL, Rohrbaugh TM, Raney Jr RB, Norris DG. Transient cortical blindness secondary to vincristine therapy in childhood malignancies. Cancer. 1981;47:37–40.
Cai Y, Pulido JS. False-positive anti-retinal antibodies as a cause of psychogenic visual loss. Ocul Immunol Inflamm. 2014;22:330–2.
Callanan D, Gass JD. Multifocal choroiditis and choroidal neovascularization associated with the multiple evanescent white dot syndrome and acute idiopathic blind spot enlargement. Ophthalmology. 1992;99:1678–85.
Campbell JK. Manifestations of migraine. Neurol Clin. 1990;8:841–55.
Candee MS, McCandless RT, Moore KR, Arrington CB, Minich LL, Bale Jr JF. White matter lesions in children and adolescents with migraine. Pediatr Neurol. 2013;49:393–6.
Caplan LR. “Top of the basilar” syndrome. Neurology. 1980;30:72–9.
Caraballo RH, Cersósimo RO, Fejerman N. Childhood occipital epilepsy of Gastaut: a study of 33 patients. Epilepsia. 2008;49:288–97.
Caraballo R, Cersósimo R, Fejerman N. Panayiotopoulos syndrome: a prospective study of 192 patients. Epilepsia. 2007;48:1054–61.
Carlow TJ. Oculomotor ophthalmoplegic migraine: is it really migraine? J Neuroophthalmol. 2002;22:215–21.
Carlsson A, Forsgren L, Nylander P-O, et al. Identification of a susceptibility locus for migraine with and without aura on 6p12.2-21.1. Neurology. 2002;59:1804–7.
Catalono RA, Simon JW, Krohel GB, Rosenberg PN. Functional visual loss in children. Ophthalmology. 1986;93:385–90.
Cavazzuti GB, Cappella L, Nalin A. Longitudinal study of epileptiform EEG patterns in normal children. Epilepsia. 1980;21:43–55.
Chary P, Rajendran B. Benign occipital seizures: natural progression and atypical evolution. Ann Indian Acad Neurol. 2013;16:556–60.
Chen CS, Lee AW, Karagiannis A, Crompton JL, Selva D. Practical clinical approaches to functional visual loss. J Clin Neurosci. 2007;14:1–7.
Chen W-T, Lin Y-Y, Fuh J-L, Hämäläinen MS, Ko Y-C, Wang S-J. Sustained visual cortex hyperexcitability in migraine with persistent visual aura. Brain. 2011;134:2387–95.
Chou YH, Wang PJ, Lin MY, Shen YZ, Lee CY. Acute hemiplegia in infancy and childhood. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1994;35:45–56.
Chu ML, Shinnar S. Headaches in children younger than 7 years of age. Arch Neurol. 1992;49:79–82.
Chun HG, Leyland-Jones BR, Caryk SM, Hoth DF. Central nervous system toxicity of fludarabine phosphate. Cancer Treat Rep. 1986;70:1225–8.
Cleves C, Friedman NR, Rothner AD, Hussain MS. Genetically confirmed CADASIL in a pediatric patient. Pediatrics. 2010;126:e1603–7.
Cogan DJ. Visual hallucinations as release phenomena. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1973;188:139–50.
Cohn R. Phantom vision. Arch Neurol. 1971;25:468–71.
Cologno D, Torelli P, Manzoni GC. Transient visual disturbances during migraine without aura attacks. Headache. 2002;42:930–3.
Congdon PJ, Forsythe WI. Migraine in childhood: a study of 300 children. Dev Med Child Neurol. 1979;21:209–16.
Connelly M. Cognitive behavioral therapy for treatment of pediatric chronic migraine. JAMA. 2013;310:2617–8.
Copperman SM. “Alice in Wonderland” syndrome as a presenting symptom of infectious mononucleosis in children: a description of three affected young people. Clin Pediatr (Phila). 1977;16:143–6.
Corbett JJ. Neuro-ophthalmic complications of migraine and cluster headaches. Neurol Clin. 1983;4:973–95.
Couch JR, Hassanein RS. Amitriptyline in migraine prophylaxis. Arch Neurol. 1979;36:695–9.
Covanis A. Panayiotopoulos syndrome: a benign childhood autonomic epilepsy frequently imitating encephalitis, syncope, migraine, sleep disorder, or gastroenteritis. Pediatrics. 2006;118:e1237–43.
Crevits L, Bosman T. Migraine-related vertigo: towards a distinctive entity. Clin Neurol Neurosurg. 2005;107:82–7.
Critchley M. Types of visual perseveration: “palinopsia” and “illusory visual spread”. Brain. 1951;74:267–99.
Cukras CA, Wong WT, Caruso R, Cunningham D, Zein W, Sieving PA. Centrifugal expansion of fundus autofluorescence patterns in Stargardt disease over time. Arch Ophthalmol. 2012;130:171–9.
Cutrer FM. Migraine: does one size fit all? Curr Opin Neurol. 2003;16:315–7.
Cutrer FM. Pathophysiology of migraine. Semin Neurol. 2010;30:120–30.
Cutrer FM, Huerter KP. Migraine aura. Neurologist. 2007;13:118–25.
Cutrer FM, Sorensen AG, Weisskoff RM, et al. Perfusion-weighted imaging defects during spontaneous migrainous aura. Ann Neurol. 1998;43:25–31.
D’Andrea G, Toldo M, Cortelazzo S, Milone FF. Platelet activity in migraine. Headache. 1982;22:207–12.
Daroff RB. Retinal migraine. J Neuroophthalmol. 2007;27:83.
Davis FA, Bergen D, Schauf C, McDonald I, Deutsch W. Movement phosphenes in optic neuritis: a new clinical sign. Neurology. 1976;26:1100–4.
De Fusco M, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump α2 subunit associated with familial hemiplegic migraine type 2. Nat Genet. 2003;33:192–6.
Denuelle M, Boulloche N, Payoux P, Fabre N, Trotter Y, Géraud GA. PET study of photophobia during spontaneous migraine attacks. Neurology. 2011;76:213–8.
Deonna T, Ziegler A-L, Despland PA. Paroxysmal visual disturbances of epileptic origin and occipital epilepsy in children. Neuropediatrics. 1984;15:131–5.
Dichgans M, Freilinger T, Eckstein G, et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet. 2005;336:371–7.
Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol. 1999;246:883–92.
Digre KB. Light sensitivity in migraineurs. Headache. 2003;43:917–20.
Digre KB, Brennan KC. Shedding light on photophobia. J Neuroophthalmol. 2012;32:68–81.
Digre KB, Durcan FJ, Branch DW, Jacobson DM, Varmer MW, Baringer JR. Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol. 1989;25:228–32.
Dobrovolny R, Liskova P, Ledvinova J, et al. Mucolipidosis IV: report of a case with ocular restricted phenotype caused by leaky splice mutation. Am J Ophthalmol. 2007;143:663–71.
Donaghy M, Chang CL, Poulter N. Duration, frequency, recency, and type of migraine and the risk of ischaemic stroke in women of childbearing age. J Neurol Neurosurg Psychiatry. 2002;73:747–50.
Dooley JM, Augustine HF, Gordon KE, Brna PM, Westby E. Alice in Wonderland and other migraine associated phenomena—evolution over 30 years of headache diagnosis. Pediatr Neurol. 2014;51:321–3.
Doyle E, Vote BJ, Casswell AG. Retinal migraine: caught in the act. Br J Ophthalmol. 2004;88:301–2.
Drummond PD. A quantitative assessment of photophobia in migraine and tension headache. Headache. 1986;26:465–9.
Drummond PD. Motion sickness and migraine: optokinetic stimulation increases scalp tenderness, pain sensitivity in the fingers and photophobia. Cephalalgia. 2002;22:117–24.
Drummond PD. Photophobia and autonomic responses to facial pain in migraine. Brain. 1997;120:1857–64.
Drummond PD, Woodhouse A. Painful stimulation of the forehead increases photophobia in migraine sufferers. Cephalalgia. 1993;13:321–3.
Duckro PN, Cantwell-Simmons EL. A review of studies evaluating biofeedback and relaxation training in the management of pediatric headache. Headache. 1989;29:428–33.
Ducros A. Familial hemiplegic migraine: a model for the genetic studies of migraine. Cephalalgia. 2014;34:1035–7.
Ducros A, Denier C, Joutel A, et al. The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel. N Engl J Med. 2001;345:17–24.
Ducros A, Joutel A, Vahedi K, et al. Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity. Ann Neurol. 1997;42:885–90.
Duncker T, Tsang SH, Lee W, et al. Quantitative fundus autofluorescence distinguishes ABCA4-associated bull’s eye maculopathy. Ophthalmology. 2015;122:345–55.
Dunn DW, Weissberg LA, Nadell J. Peduncular hallucinosis caused by brainstem compression. Neurology. 1983;33:1360–1.
Durkan GP, Troost BT, Slamovits TL, Spoor TC, Kennerdell JS. Recurrent painless oculomotor palsy in children. A variant of ophthalmoplegic migraine? Headache. 1981;21:58–62.
Dutton GN, McKillop EC, Saidkasimova S. Visual problems as a result of brain damage in children. Br J Ophthalmol. 2006;90:932–3.
Dvorkin G, Andermann F, Melancon D, et al. Malignant migraine syndrome: classical migraine, occipital seizures, and alternating strokes. Neurology. 1984;34:245. Abstract.
Eames TH. A study of tubular and spiral central fields in hysteria. Am J Ophthalmol. 1947;30:610–1.
Eapen A, Sivaswamy L. Unilateral pupillary dilatation in an 11-year-old girl. Pediatr Neurol. 2014;50:117–8.
Eapen A, Sivaswamy L, Agarwal R, Thomas R. Management of pediatric migraine in a tertiary care versus community based emergency department: an observational pilot study. Pediatr Neurol. 2014;50:164–70.
Edgell HG, Kolvin I. Childhood hallucinations. J Child Psychol Psychiatry. 1972;13:279–87.
Egan RA. Ocular motor features of alternating hemiplegia of childhood. J Neuroophthalmol. 2002;22:99–101.
Ehrt O. Posterior pole ectasia as a rare cause of amblyopia not responsive to therapy. Presented as a poster at the International Strabismological Association, Kyoto, Japan, Dec 1-4; 2014.
Ehyai AB, Fenichel GM. The natural history of acute confusional migraine. Arch Neurol. 1978;35:368–9.
Eiland LS, Hunt MO. The use of triptans for pediatric migraines. Paediatr Drugs. 2010;12:379–89.
El-Chammas K, Keyes J, Thompson N, Vijayakumar J, Becher D, Jackson JL. Pharmacologic treatment of pediatric headaches: a meta-analysis. JAMA Pediatr. 2013;167:250–8.
Elliot D, Traboulsi EI, Maumenee IH. Visual prognosis in autosomal dominant optic atrophy (Kjer type). Am J Ophthalmol. 1993;115:360–7.
Elser JM, Woody RC. Migraine headache in the infant and young child. Headache. 1990;30:366–8.
Emery 3rd ES. Acute confusional state in children with migraine. Pediatrics. 1977;60:110–4.
Engelsen BA, Tzoulis C, Karlsen B, et al. POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain. 2008;131:818–28.
Epstein LG, Zee PC. Infantile colic and migraine. JAMA. 2013;309:1636–7.
Erbek SH, Erbek SS, Yilmaz I, et al. Vertigo in childhood: a clinical experience. Int J Pediatr Otorhinolaryngol. 2006;70:1547–54.
Espinosa-Sanchez JM, Lopez-Excamez JA. New insights into pathophysiology of vestibular migraine. Front Neurol. 2015;6:12. doi:10.3389/fneur.2015.00012.eCollection 2015. Review.
Evans RW, Digre KB. Light sensitivity in migraineurs. Headache. 2003;43:917–20.
Fang W, Huang C-C, Lee C-C, Cheng S-Y, Pang C-Y, Wei Y-H. Ophthalmologic manifestations in MELAS syndrome. Arch Neurol. 1993;50:977–80.
Faria V, Linnman C, Lebel A, Borsook D. Harnessing the placebo effect in pediatric migraine clinic. J Pediatr. 2014;165:659–65.
Feinberg WM, Rapcsak SZ. “Peduncular hallucinosis” following paramedian thalamic infarction. Neurology. 1989;39:1535–6.
Ferreira J, Garcia N, Pedreira L. Topiramate in pediatric and adolescent migraine patients: a retrospective analysis (abstract). Headache. 2002;42:453.
Ferrie C, Caraballo R, Covanis A, et al. Panayiotopoulos syndrome: a consensus view. Dev Med Child Neurol. 2006;48:236–40.
Fisher CM, Adams RD. Transient global amnesia. Trans Am Neurol Assoc. 1958;83:143–5.
Fisher CM. Late-life migraine accompaniments as a cause of unexplained transient ischemic attacks. Can J Neurol Sci. 1980;7:9–17.
Fishman GA, Farber M, Patel BS, Derlacki DJ. Visual acuity loss in Stargardt’s macular dystrophy. Ophthalmology. 1987;94:809–14.
Fletcher WA, Imes RK, Goodman D, Hoyt WF. Acute idiopathic blind spot enlargement. A big blind spot syndrome without optic disc edema. Arch Ophthalmol. 1988;106:44–9.
Forsyth WI, Gillies D, Sills M. Propranolol (“Inderal”) in the treatment of childhood migraine. Dev Med Child Neurol. 1984;26:737–41.
Friedman DI. The ophthalmoplegic migraines: a proposed classification. Cephalalgia. 2010;30:646–7.
Friedman JR, Kosmorsky JS, Burde RM. Stereoacuity in patients with optic nerve disease. Arch Ophthalmol. 1985;103:37–8.
Frisen L, Hoyt WF, Bird AC, Weale RA. Diagnostic uses of the Pulfrick phenomenon. Lancet. 1973;18:375–6.
Frosk P, Mhanni AA, Rafay MF. SCN1A mutation associated with intractable myoclonic epilepsy and migraine headache. J Child Neurol. 2013;28:389–91.
Fujinami K, Lois N, Davidson AE, et al. A longitudinal study of Stargardt disease: clinical and electrophysiologic assessment, progression, and genotype correlations. Am J Ophthalmol. 2013;155:1075–88.
Fujinami K, Zernant J, Chana RK, et al. Clinical and molecular characteristics of childhood-onset Stargardt disease. Ophthalmology. 2015;122:326–34.
Fusco L, Vigevano F. Alternating hemiplegia of childhood: clinical finding during attacks. In: Anderman F, Aicardi J, Vigevano F, editors. Alternating Hemiplegia of Childhood. New York: Raven Press; 1995. p. 29–41.
Gallanti A, Cardin V, Tonelli A, et al. The genetic features of 24 patients affected by familial and sporadic hemiplegic migraine. Neurol Sci. 2011;32S:S141–2.
Gancher ST, Nutt JG. Autosomal dominant episodic ataxia: a heterogenous syndrome. Mov Disord. 1986;1:329–53.
Gardner-Thorpe C, Kocen RS. Subacute sclerosing panencephalitis presenting as transient homonymous hemianopia. J Neurol Neurosurg Psychiatry. 1983;46:186–7.
Garralda ME. Hallucinations in children with conduct and emotional disorders. I: the clinical phenomena. Psychol Med. 1984;14:589–96.
Garralda ME. Hallucinations in children with conduct and emotional disorders. II: the follow-up study. Psychol Med. 1984;14:597–604.
Gascon GG. Chronic and recurrent headaches in children and adolescents. Pediatr Clin North Am. 1984;31:1027–51.
Gascon G, Barlow C. Juvenile migraine presenting as an acute confusional state. Pediatrics. 1970;45:628–35.
Gasparini CF, Sutherland HG, Griffith LR. Studies on the pathophysiology and genetic basis of migraine. Curr Genomics. 2013;14:300–15.
Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment, I. 3rd ed. St Louis, MO: CV Mosby; 1987. p. 256–8.
Gastaut H. A new type of epilepsy: benign partial epilepsy of childhood with occipital spike-waves. Clin Electroencephalogr. 1982;13:13–22.
Gastaut H. Benign epilepsy of childhood with occipital paroxysms. In: Roger J, Dravet CH, Bureau M, Dreiffus FE, Wolf P, editors. Epileptic Syndromes in Infancy, Childhood and Adolescence. London: John Libbey; 1995. p. 150–70.
Gastaut H. Clinical Analysis in the Epilepsies: Electroclinical Correlations. Springfield: Charles C. Thomas; 1954. p. 8–44.
Gefland AA, Thomas KC, Goadsby PJ. Before the headache: infant colic as an early life expression of migraine. Neurology. 2012;79:1392–6.
Geller TJ, Bellur SN. Peduncular hallucinosis: magnetic resonance imaging confirmation of mesencephalic infarction during life. Ann Neurol. 1987;21:602–4.
Gibbs FA, Gibbs EL. Atlas of Electroencephalography, II: Epilepsy. Cambridge, MA: Addison-Wesley Press; 1952. p. 222–4.
Giffin NJ, Benton S, Goadsby PJ. Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNAIA mutation. Dev Med Child Neurol. 2002;44:490–3.
Giffen NJ, Ruggiero L, Lipton RB, et al. Premonitory symptoms in migraine: an electronic diary study. Neurology. 2003;60:935–40.
Gittinger Jr JW, Miller NR, Keltner JL, Burde RM. Sugarplum fairies: visual hallucinations. Surv Ophthalmol. 1982;27:42–8.
Glista GG, Mellinger JF, Rooke ED. Familial hemiplegic migraine. Mayo Clin Proc. 1975;50:307–11.
Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules, and therapeutics. Trends Mol Med. 2007;13:39–44.
Goadsby PJ. Sporadic hemiplegic migraine: stamp collecting or food for thought? Neurology. 2003;60:536–7.
Goadsby PJ. Stress and migraine: something expected, something unexpected. Neurology. 2014;82:1388–9.
Goadsby PJ, Duckworth JW. Effect of stimulation of trigeminal ganglion on regional cerebral blood flow in cats. Am J Physiol. 1987;253:R270–4.
Goadsby PJ, Hoskin KL. The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study. J Anat. 1997;190:367–75.
Goadsby PJ, Kullmann DK. Another migraine gene. Lancet. 2005;366:345–6.
Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and treatment. N Engl J Med. 2002;346:257–70.
Goadsby PJ, Silberstein SD. Headache. In: Asbury A, Marsden CD, editors. Blue Books in Practical Neurology. New York: Butterworth-Heinemann; 1997.
Gold K, Rabins PV. Isolated visual hallucinations and the Charles Bonnet syndrome: a review of the literature and presentation if six cases. Compr Psychiatry. 1989;30:90–8.
Golden GS. The Alice in Wonderland syndrome in juvenile migraine. Pediatrics. 1979;63:517–9.
Gomes NL, Greenstein VC, Carlson JN, et al. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease. Invest Ophthalmol Vis Sci. 2009;50(8):3953–9.
Gonzalez-Cuevas M, Toledo M, Santamarina E, et al. Visual epileptic seizures: signs and symptoms, can clinical implications. Rev Neurol. 2015;60:257–62.
Good PA, Taylor RH, Mortimer MJ. The use of tinted glasses in childhood migraine. Headache. 1991;31:533–6.
Goodale MA, Milner AD. Sight Unseen: An Exploration of Conscious and Unconscious Vision. Oxford: Oxford University Press; 2005.
Goto Y, Horai S, Matsuoka T, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes (MELAS): a correlative study of the clinical features and mitochondrial DNA mutation. Neurology. 1992;42:545–50.
Gowers WR. Cases of cerebral tumor illustrating diagnosis and localization. Lancet. 1879;1:363–5.
Graefe A. Über ein einfaches Mittel, Sinulation einseitiger Amaurose zu entdecken, nebst Bemerkungen über die Pupillar-Kontracktion bei Erblindeten. Graefe’s Arch Ophthalmol. 1855;2:266–72.
Graether JM. Transient amaurosis in one eye with simultaneous dilation of retinal veins: in association with a congenital anomaly of the optic nerve head. Arch Ophthalmol. 1963;70:342–5.
Graf WD, Chatrian GE, Glass ST, Knauss TA. Video game-related seizures: a report on 10 patients and a review of the literature (review). Pediatrics. 1994;93:551–6.
Grant WM. Toxicology of the Eye. 2nd ed. Springfield, IL: Charles C. Thomas; 1974. p. 55–6.
Greenblatt SH. Post-traumatic cerebral blindness: association with migraine and seizure diathesis. JAMA. 1973;225:1073–6.
Gross C. The many faces of infectious mononucleosis: the spectrum of Epstein-Barr virus infection in children. Pediatr Rev. 1985;7:35–44.
Grüter T, Grüter M. An underestimated handicap: congenital prosopagnosia. Geneva: EUPO course; 2008. p. 51–53, Sept. 5–7.
Grüter M, Grüter T, Bell V, et al. Hereditary prosopagnosia: the first case series. Cortex. 2007;43:734–49.
Grüter T, Grüter M, Carbon CC. Neural and genetic foundations of face recognition and prosopagnosia. J Neuropsychol. 2008;2:79–97.
Guggenheim FG, Smith GR. Somatoform disorders. In: Kaplan BJ, Sadock BJ, editors. Comprehensive Textbook of Psychiatry. 6th ed. Baltimore: Williams and Wilkins; 1995. p. 1251–70.
Guilleminault C, editor. Sleep and Its Disorders in Children. New York: Raven Press; 1987. p. 181–3.
Guilleminault C. Narcolepsy. In: Chokroverty S, editor. Sleep Disorders Medicine: Basic Science, Technical Considerations, and Clinical Aspects. Boston: Butterworth Heinemann; 1994. p. 241–3.
Haan J, Terwindt GM, Ferrari MD. Genetics of migraine. Adv Headache. 1997;15:43–60.
Hachinski VC, Porchawka J, Steele JC. Visual symptoms in the migraine syndrome. Neurology. 1973;23:570–9.
Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001;98:4687–92.
Hakkarainen J, Quiding H, Stockman O. Mild analgesics as an alternative to ergotamine in migraine: a comparative trial with acetylsalicylic acid, ergotamine tartrate, and dextropropoxyphene compound. J Clin Pharmacol. 1980;20:590–5.
Hämäläinen ML, Hoppu K, Valkeila E, Santavuori P. Ibuprofen or acetaminophen for the acute treatment of migraine in children. Neurology. 1997;48:103–7.
Hamed LM, Glaser JS, Gass JDM, Schatz NJ. Protracted enlargement of the blind spot in multiple evanescent white dot syndrome. Arch Ophthalmol. 1989;107:194–8.
Hanington E. Migraine: a blood disorder? Lancet. 1978;1:501–2.
Hanson RR. Headaches in childhood. Semin Neurol. 1988;8:51–60.
Harding GF, Wild JM, Robertson KA, et al. Electro-oculography, electroretinography, visual evoked potentials, and multifocal electroretinography in patients with vigabatrin-attributed visual field constriction. Epilepsia. 2000;41:1420–31.
Harris W. Hemianopsia with special reference to its transient varieties. Brain. 1897;20:308–64.
Hartong DT, Pott J-WR, Kooijman AC. Six patients with bradyopsia (slow vision): clinical features and course of the disease. Ophthalmology. 2007;114:2323–31.
Hauser RA, Lacey M, Knight R. Hypertensive encephalopathy: magnetic resonance imaging demonstration of reversible cortical and white matter lesions. Arch Neurol. 1988;45:1078–83.
Headache Classification Committee of the International Headache Society (IIH). The International Classification of Headache Disorders, 3rd ed (beta version). Cephalalgia. 2013;33:629–808.
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24:9–160.
Havanka-Kanniainen H. Treatment of acute migraine attack: ibuprofen and placebo compared. Headache. 1989;29:507–9.
Hewitt DJ, Aurora SK, Dodick DW, et al. Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the treatment of migraine. Cephalalgia. 2011;31:712–22.
Hewitt DJ, Pearlman E, Hämäläinen M, et al. Long-term open-label safety study of Rizatriptan acute treatment in pediatric migraineurs. Headache. 2013;53:104–17.
Hicks PA, Leavitt JA, Mokris B. Ophthalmic manifestations of vertebral artery dissection: patients seen at the Mayo Clinic from 1976–1992. Ophthalmology. 1994;101:1786–92.
Highley M, Meller ST, Pinkerton CR. Seizures and cortical dysfunction following high-dose cisplatin administration in children. Med Pediatr Oncol. 1992;20:143–8.
Hill DL, Daroff RB, Ducros A, Newman NJ, Biousse V. Most cases labeled as “retinal migraine” are not migraine. J Neuroophthalmol. 2007;27:3–8.
Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494–500.
Hirai T, Sato M, Kachi S, et al. Similar etiologies of functional visual loss observed in children and adults. Binocul Vis Strabismus Q. 2005;20:218–23.
Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol. 1994;9:4–13.
Ho CS, Shen EY, Liaw SB, Huang FY. Clinical observation and neurological outcomes in “Alice in Wonderland” syndrome. Zhoghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi. 1992;33:89–95.
Hockaday JM. Basilar migraine in childhood. Dev Med Child Neurol. 1979;21:455–63.
Holder G, Gale RP, Acheson JF, Robson AG. Electrodiagnostic assessment in optic nerve disease. Curr Opin Neurol. 2009;22:3–10.
Holmes G. Sabill memorial oration on local epilepsy. Lancet. 1927;1:957–62.
Holtzman RN, Goldensohn ES. Sensations of ocular movement in seizures originating in occipital lobe. Neurology. 1977;27:554–6.
Hoyt CS. Autosomal dominant optic atrophy. A spectrum of disability. Ophthalmology. 1980;87:245–51.
Hughes MS, Lessell S. Trazadone-induced palinopsia. Arch Ophthalmol. 1990;108:399–400.
Hupp SL, Kline LB, Corbett JJ. Visual disturbances of migraine. Surv Ophthalmol. 1989;33:221–36.
Huppertz H-J, Franck P, Korinthenberg R, Schulze-Bonhage A. Recurrent attacks of fear and visual hallucinations in a child. J Child Neurol. 2002;17:230–3.
International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004;24 Suppl 1:1–160.
Ip JM, Robaei D, Rochtchina E, Mitchell P. Prevalence of eye disorders in young children with eyestrain complaints. Am J Ophthalmol. 2006;142:495–7.
Jacobson LK, Dutton GN. Periventricular leukomalacia: an important cause of visual and ocular motility dysfunction in children. Surv Ophthalmol. 2000;45:1–13.
Jäger HR, Giffin NJ, Goadsby PJ. Diffusion- and perfusion-weighted MR imaging and persistent migrainous visual disturbances. Cephalalgia. 2005;25:323–32.
Jahn K, Langhagen T, Schroeder AS, Heinen F. Vertigo and dizziness in childhood—update on diagnosis and treatment. Neuropediatrics. 2011;42:129–34.
Jan MM. History of motion sickness is predictive of childhood migraine. J Paediatr Child Health. 1998;34:483–4.
Jardri R, Bartels-Velthius AA, Debbané M, et al. From phenomenology to neurophysiological understanding of hallucinations in children and adolescents. Schizophr Bull. 2014;40:S221–32.
Jayasundera T, Rhoades W, Branham K, Niziol LM, Musch DC, Heckenlively JR. Peripapillary dark choroid ring as a helpful diagnostic sign in advanced Stargardt disease. Am J Ophthalmol. 2010;149:656–60.
Jorgensen KA, Sorensen P, Freund L. Effective glucocorticosteroids on some coagulation tests. Acta Hematol [Basel]. 1982;68:39–42.
Josephson SA, Kirsch HE. Complex visual hallucinations as post-ictal cortical release phenomena. Neurocase. 2006;12:107–10.
Joutel A, Bousser M-G, Biousse V, et al. A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet. 1993;5:40–5.
Jürgen TP, Schulte LH, May A. Migraine trait symptoms in migraine with and without aura. Neurology. 2014;82:1413–24.
Kabuto T, Takahashi H, Goto-Fukuura Y, et al. A new mutation in the RP1L1 gene in a patient with occult macular dystrophy associated with a depolarizing pattern of focal macular electroretinograms. Mol Vis. 2012;18:1031–9.
Kaiser HJ, Flammer J, Gasser P. Ocular vasospasm in children. Neuro-ophthalmology. 1993;13:263–7.
Kaminer Y, Hrecznyj B. Lysergic acid diethylamide-induced chronic visual disturbances in an adolescent. J Nerv Ment Dis. 1991;179:173–4.
Kanavakis E, Xaidara A, Papathanasiou-Klontza D, Velentza S, Youroukos S. Alternating hemiplegia of childhood: a syndrome inherited with an autosomal dominant trait. Dev Med Child Neurol. 2003;45:833–6.
Karatas H, Erdener SE, Gursoy-Ozdemir Y, et al. Spreading depression triggers headache by activating neuronal Panx1 channels. Science. 2013;339:1092–5.
Karlson CW, Litzenburg CC, Sampilo ML, et al. Relationship between daily mood and migraine in children. Headache. 2013;53:1624–34.
Kasteijn-Nolst-Trenité D, Rubboli G, Hirsch E, et al. Methodology of photic stimulation revisited: updated European algorithm for visual stimulation in the EEG laboratory. Epilepsia. 2012;53:16–24.
Kathol RG, Cox TA, Corbett JJ, Thompson HS, Clancy J. Functional visual loss. I: a true psychiatric disorder? Psychol Med. 1983;13:307–14.
Kathol RG, Cox TA, Corbett JJ, Thompson HS, Clancy J. Functional visual loss. II: psychiatric aspects in 42 patients followed for 4 years. Psychol Med. 1983;13:315–24.
Kathol RG, Cox TA, Corbett JJ, Thompson HS. Functional visual loss: follow-up of 42 cases. Arch Ophthalmol. 1983;101:729–35.
Katz B, Hoyt WF. Intrapapillary and peripapillary hemorrhage in young patients with uncomplicated posterior vitreous detachment: signs of vitreopapillary traction. Ophthalmology. 1995;102:349–54.
Kaube H, Keay KA, Hoskin KL, Bandler R, Goadsby PJ. Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical cord following stimulation of the superior sagittal sinus in the cat. Brain Res. 1993;629:95–102.
Kaul S, Uparkar M, Sivaraman A, et al. Isolated foveal hypoplasia with good visual acuity and absence of nystagmus. JAAPOS. 2008, in press.
Kinast M, Lueders H, Rothner AD, Erenberg G. Benign focal epileptiform discharges in childhood migraine (BFEDC). Neurology. 1982;32:1309–12.
Kinetz E. Is hysteria real? Brain images say yes. New York Times; Sept. 26, 2006.
King RA. Common ocular signs and symptoms in children. Pediatr Clin North Am. 1993;40:753–66.
Kline LB, Glaser JS. Dominant optic atrophy: the clinical profile. Arch Ophthalmol. 1979;97:1680–6.
Kline LB, Kelly CL. Ocular migraine in a patient with cluster headaches. Headache. 1980;20:253–7.
Kloster R, Nestvold K, Vilming ST. A double-blind study of ibuprofen versus placebo in the treatment of acute migraine attacks. Cephalalgia. 1992;12:169–71.
Knight YE, Goadsby PJ. The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience. 2001;106:793–800.
Kondo M, Ueno S, Piao C-H, Ito Y, Teresaki H, Miyake Y. Occult macular dystrophy in an 11 year old boy. Br J Ophthalmol. 2004;88:1602–3.
Kooi KA. Episodic blindness as a late effect of head trauma: electrophysiological study of three cases. Neurology. 1970;20:569–73.
Kosnik E, Paulson GW, Laguna JF. Postictal blindness. Neurology. 1976;26:248–50.
Koutroumanidis M. Panayiotopoulos syndrome. Br Med J. 2002;324:1228–9.
Kruit MC, van Buchem MA, Hofman PAM, et al. Migraine as a risk factor for subclinical brain lesions. JAMA. 2004;291:427–34.
Kruuse C, Thomsen LL, Birk S, Olesen J. Migraine can be induced by sildenafil without changes in middle cerebral artery diameter. Brain. 2003;126:241–7.
Kupersmith MJ. Neurovascular Neuro-ophthalmology. New York: Springer; 1993. p. 452–3.
Kupersmith MJ, Warren FA, Hass WK. The nonbenign aspects of migraine. Neuro-ophthalmology. 1987;7:1–10.
Laffi GL, Safran AB. Persistent visual hallucinations following hashish consumption. Br J Ophthalmol. 1993;77:601–2.
Lagae L. What’s new in: “genetics in childhood epilepsy”. Eur J Pediatr. 2008;167:715–22.
Lai TYY, Chan W-M, Lai RYK, Ngai JWS, Li H, Lam DSC. The clinical applications of multifocal electroretinography: a systematic review. Surv Ophthalmol. 2007;52:61–96.
Lambertus S, van Huet RAC, Bax NM, et al. Early-onset Stargardt disease: phenotypic and genotypic characteristics. Ophthalmology. 2015;122:335–44.
Lance JW. Simple formed hallucinations confined to the area of a specific visual field defect. Brain. 1976;99:719–34.
Lanska JR, Lanska DJ. Alice in Wonderland syndrome: somesthetic vs visual perceptual disturbance. Neurology. 2013;80:1262–4.
Lanska DJ, Lanska MJ. Visual “release” hallucinations in juvenile neuronal ceroid-lipofuscinosis. Pediatr Neurol. 1993;9:316–7.
Lanska DJ, Lanska MJ, Mendez MF. Brainstem auditory hallucinosis. Neurology. 1987;37:1685.
Lapkin ML, Golden GS. Basilar artery migraine: a review of 30 cases. Am J Dis Child. 1978;132:278–81.
Lashley KS. Patterns of cerebral integration indicated by scotomas of migraine. Arch Neurol Psychiatry. 1941;46:331–9.
Lauritzen M. Cortical spreading depression as a putative migraine mechanism. Trends Neurosci. 1987;10:8–13.
Lauritzen M. Pathophysiology of the migraine aura: the spreading depression theory. Brain. 1994;117:199–210.
Lauritzen M, Olesen J. Regional cerebral blood flow during migraine attacks by xenon 133 inhalation and emission tomography. Brain. 1984;107:447–61.
La Vega-Talbot M, Duchowny M, Jayakar P. Orbitofrontal seizures presenting with ictal visual hallucinations and interictal psychosis. Pediatr Neurol. 2006;35:78–81.
Lawden MC, Eke T, Degg C, Harding GFA, Wild JM. Visual field defects associated with vigabatrin therapy. J Neurol Neurosurg Psychiatry. 1999;67:716–22.
Lee M, Brace J, McKinney A, Santa-Cruz K. Progressive visual loss in a man with leukemia. Presented at the Frank B Walsh Society Meeting, Lake Tahoe, Nevada on February 22, 2008.
Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1988;318:1148–52.
Lehnen N, Langhagen T, Heinen F, Huppert D, Brandt T, Jahn K. Vestibular paroxysmia in children: a treatable cause of short vertigo attacks. Dev Med Child Neurol. 2014, in press.
Leo AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol. 1944;7:359–90.
Lepore FE. Dr. Airy’s “morbid affection of the eyesight”: lessons from teichopsia circa 1870. J Neuroophthalmol. 2014;34:311–4.
Lepore FE. Spontaneous visual phenomenon with visual loss: 104 patients with lesions of the retinal and neural afferent pathways. Neurology. 1990;40:444–7.
Lepore FE. Uhthoff’s symptoms in disorders of the anterior visual pathways. Neurology. 1994;44:1036–8.
Lessell S. Higher disorders of visual function: positive phenomenon. In: Glaser JS, Smith JL, editors. Neuro-ophthalmology, vol. VIII. St. Louis: C.V. Mosby; 1975. p. 27–44.
Lessell S. Nonorganic visual loss: what’s in a name. Am J Ophthalmol. 2011;151:569–71.
Lessell S, Cohen MM. Phosphenes induced by sound. Neurology. 1979;38:1524–6.
Levi L, Miller NR. Visual illusions associated with previous drug allergy. J Clin Neuroophthalmol. 1990;10:103–10.
Lewis D, Ashwal S, Dahl G, et al. American Academy of Neurology practice parameter: evaluation of children and adolescents with recurrent headaches. Neurology. 2002;59:490–8.
Lewis D, Ashwal S, Hershey A, Hirtz D, Yonker M, Silberstein S. Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society. Neurology. 2004;63:2215–24.
Lewis DW, Diamond S, Scott D, Jones V. Prophylactic treatment of pediatric migraine. Headache. 2004;44:230–7.
Lewis DW, Kellstein D, Dahl G, et al. Children’s ibuprofen suspension for the acute treatment of pediatric migraine. Headache. 2002;42:780–6.
Lewis RA, Vijayan N, Watson C, Keltner J, Johnson CA. Visual field loss in migraine. Ophthalmology. 1989;96:321–6.
Lhermitte J. Syndrome de la calotte du pedoncule cerebral. Les troubles psycho-sensoriels dans les lesions du mesodphale. Rev Neurol (Paris). 1922;38:1359–65.
Liaw SB, Shen EY. Alice in Wonderland syndrome as a presenting symptom of EBV infection. Pediatr Neurol. 1991;7:464–6.
Lim SA, Siatkowski RM, Farris BK. Functional visual loss in adults and children: patient characteristics, management, and outcomes. Ophthalmology. 2005;112:1821–8.
Limmroth V, May A, Auerbach P, Wosnitza G, Eppe T, Diener HC. Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine. J Neurol Sci. 1996;138:60–5.
Lippman CW. Certain hallucinations peculiar to migraine. J Nerv Ment Dis. 1952;116:346–51.
Lipton RB, Buse DC, Hall CB, et al. Reduction in perceived stress as a migraine trigger: testing the “let-down headache” hypothesis. Neurology. 2014;82:1395–401.
Lipton RB, Ottman R, Ehrenberg BL, Hauser WA. Comorbidity of migraine: the connection between migraine and epilepsy. Neurology. 1994;44 Suppl 7:S28–S32.
Lipton RB, Pan J. Is migraine a progressive brain disease? JAMA. 2004;28:493–4.
Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646–57.
Little RD, Goldstein JL. Alexia without agraphia in a child with acute disseminated encephalomyelitis. Neurology. 2006;67:725.
Liu GT, Schatz NJ, Galetta SL, Volpe NJ, Skobieranda F, Kosmorsky GS. Persistent positive visual phenomena in migraine. Neurology. 1995;45:664–8.
Loewenstein JI. Visual hallucinations in patients with choroidal neovascularization. JAMA. 1994;272:243.
Lorentzen SE. Drusen of the optic disk. A clinical and genetic study. Dan Med Bull. 1967;14:293–8.
Losada-Del Pozo R, Cantarín-Extremera V, García-Peñas JJ, et al. Characteristics and evolution of patients with Alice in Wonderland syndrome [article in Spanish]. Rev Neurol. 2011;53:641–8.
Lowery RS, Atkinson D, Lambert SR. Cryptic cerebral impairment in children. Br J Ophthalmol. 2006;90:960–3.
Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand. 1974;50:109–15.
Ludwig BI, Marsan CA. Clinical ictal patterns in epileptic patients with occipital electroencephalographic foci. Neurology. 1975;25:463–71.
MacDonald JT. Childhood migraine: differential diagnosis and treatment. Postgrad Med. 1986;80:301–4, 306.
MacDonald JT. Treatment of juvenile migraine with subcutaneous sumatriptan. Headache. 1994;34:581–2.
Mack KJ. Headaches in children. In: Aicardi J, editor. Diseases of the Nervous System in Childhood. 4th ed. Wiley Press; 2015, in press.
Mackenzie R, Klistorner A. Severe persistent visual field constriction associated with vigabatrin: asymptomatic as well as symptomatic defects occur with vigabatrin. BMJ. 1998;316:233.
Macnab AJ, Bennett M. Refrigerator blindness: selective loss of visual acuity in association with a common foraging behavior. CMAJ. 2005;173:1494–5.
Magis D. Neuromodulation in migraine. State of the art and perspectives. Expert Rev Med Devices. 2015; epub ahead of print.
Maitland CG. Ocular motility in childhood migraine. Presented at the North American Neuro-Ophthalmological Society Meeting, Rancho Bernardo, CA; February 23–27, 1992.
Maleki N, Becerra L, Upadhyay J, Burstein R, Borsook D. Direct optic nerve pulvinar connections defined by diffusion MR tractography in humans: implications for photophobia. Hum Brain Mapp. 2012;33:75–88.
Manford M, Andermann F. Complex visual hallucinations: clinical and neurobiological insights. Brain. 1998;121:1819–40.
Mäntyjärvi MI. The amblyopic schoolgirl syndrome. J Pediatr Ophthalmol Strabismus. 1981;18:30–3.
Marini C, Conti V, Mei D, et al. PRRT mutations in familial infantile seizures, paroxysmal dyskinesia, and hemiplegic migraine. Neurology. 2012;79:2109–14.
Mark AS, Casselman J, Brown D, et al. Ophthalmoplegic migraine: reversible enhancement and thickening of the cisternal segment of the oculomotor nerve on contrast-enhanced MRI images. AJNR Am J Neuroradiol. 1998;19:1887–91.
Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia. 1988;8:83–91.
Marra TR, Shah M, Mikus MA. Transient cortical blindness due to hypertensive encephalopathy. Magnetic resonance imaging correlation. J Clin Neuroophthalmol. 1993;13:35–7.
Martinovic Z. Panayiotopoulos syndrome. Lancet. 2001;358:69.
Martins-Ferreira H, de Castro GO. Light-scattering changes accompanying spreading depression in isolated retina. J Neurophysiol. 1966;29:715–26.
Martins-Ferreira H, Nedergaard M, Nicholson C. Perspectives on spreading depression. Brain Res Rev. 2000;32:215–34.
Martyn LJ. Discussion of Catalano et al. Functional visual loss in children. Ophthalmology. 1986;93:390.
Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital sitmulators: a PET study. Brain. 2004;127:220–30.
Matthews PM, Tampieri D, Berkovic SF, et al. Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology. 1991;41:1043–6.
Matthews GP, Sandberg MA, Berson EL. Foveal cone electroretinograms in patients with central visual loss of unexplained etiology. Arch Ophthalmol. 1992;110:1568–70.
McAbee GN, Morse AM, Assadi M. Pediatric aspects of headache classification in the International Classification of Headache Disorders-3 (ICHD-3 beta version). Curr Pain Headache Rep. 2016;20:1–7.
McBain VA, Townend J, Lois N. Progression of retinal pigment epithelial atrophy in Stargardt disease. Am J Ophthalmol. 2012;154:146–54.
McKendrick AM, Badcock DR. Decreased visual field sensitivity measured 1 day, then 1 week, after migraine. Invest Ophthalmol Vis Sci. 2004;45:1061–70.
McKillop E, Dutton GN. Impairment of vision in children due to damage to the brain: a practical approach. Br Ir Orthopt J. 2008;5:8–14.
Meldrum BS, Brierly JB. Prolonged epileptic seizures in primates: ischemic cell change and its relation to ictal physiological events. Arch Neurol. 1973;28:10–7.
Mewasingh LD, Kornreich C, Christiaens F, Christophe C, Dan B. Pediatric phantom vision (Charles Bonnet) syndrome. Pediatr Neurol. 2002;26:143–5.
Michaelides M, Holder GE, Bradshaw K, Hunt DM, Mollon JD, Moore AT. Oligocone trichromacy: a rare and unusual cone dysfunction syndrome. Br J Ophthalmol. 2004;88:497–500.
Mierzwiński J, Polak M, Dalke K, Burduk P, Kaźmierczak H, Modrzyński M. Benign paroxysmal vertigo of childhood. Otolaryngol Pol. 2007;61:307–10.
Mikati MA, Maguire H, Barlow CF, et al. A syndrome of autosomal dominant alternating hemiplegia: clinical presentation mimicking intractable epilepsy: chromosomal studies; and physiologic investigations. Neurology. 1992;42:2251–7.
Miller BW. A review of practical tests for ocular malingering and hysteria. Surv Ophthalmol. 1973;17:241–6.
Miller NR. Walsh and Hoyt’s Clinical Neuro-ophthalmology, vol. III. 4th ed. Baltimore: Williams and Wilkins; 1995. p. 1398.
Miller SP, Sanchez-Avalos J, Stefanski T, Zuckerman L. Coagulation disorders in cancer I: clinical and laboratory studies. Cancer. 1967;20:1452–65.
Miyake Y, Horiguchi M, Tomita N, et al. Occult macular dystrophy. Am J Ophthalmol. 1996;122:644–53.
Miyake Y, Ichikawa K, Shiose Y, Kawase Y. Hereditary macular dystrophy without visible fundus abnormality. Am J Ophthalmol. 1989;1108:292–9.
Miyamoto S, Kikuchi H, Karasawa J, Nagata I, Ihara I, Yamagata S. Study of the posterior circulation in moyamoya disease. Part 2: visual disturbances and surgical treatment. J Neurosurg. 1986;65:454–60.
Monteiro JM, Rosas MJ, Correia AP, Vaz AR. Migraine and intracranial vascular malformations. Headache. 1993;33:563–5.
Morelli N, Rota E. Migraine and patient foramen ovale: barking up the wrong tree? Front Neurol. 2014;5:1–2.
Mortimer MJ, Kay J, Jaron A. Childhood migraine in general practice: clinical features and characteristics. Cephalalgia. 1992;12:238–43.
Mortimer MJ, Kay J, Jaron A. Epidemiology of headache and childhood migraine in an urban general practice using ad hoc, vahlquist and IHS criteria. Dev Med Child Neurol. 1992;34:1096–101.
Moskowitz MA, Cutrer FM. Sumatriptan: a receptor-targeted treatment for migraine. Annu Rev Med. 1993;44:145–54.
Munk MR, Jampol LR, Cunha Souza E, et al. New associations of classic acute macular neuroretinopathy. Br J Ophthalmol. 2015, in press.
Nadvi SS, van Dellen JR. Transient peduncular hallucinations secondary to brain stem compression by a medulloblastoma. Surg Neurol. 1994;41:250–2.
Nagendran K, Prior PF, Rossiter MA. Benign occipital epilepsy of childhood: a family study. J R Soc Med. 1989;82:684–5.
Natowicz M, Kelley RI. Mendelian etiologies of stroke. Ann Neurol. 1987;22:175–92.
Neuhauser H, Lempert T. Vertigo and dizziness related to migraine: a diagnostic challenge. Cephalalgia. 2004;24:83–91.
Newmark ME. Visual hallucinations. JAMA. 1987;257:82. Letter.
Ney JJ, Volpe NJ, Liu GT. Functional visual loss in idiopathic intracranial hypertension. Ophthalmology. 2009;116:1808–13.
Norton JW, Corbett JJ. Visual perceptual abnormalities: hallucinations and illusion. Semin Neurol. 2000;20:111–21.
Noseda R, Burstein R. Advances in understanding the mechanisms of migraine-type photophobia. Nat Neurosci. 2010;13:239–45.
Nyhold DR, Dawkins JL, Brimage PJ, Goadsby PJ, Nicholson GA, Griffiths LR. Evidence for an X-linked genetic component in familial typical migraine. Hum Mol Genet. 1998;7:459–63.
O’Connor PJ, Tredici TJ. Acephalgic migraine: fifteen years experience. Ophthalmology. 1981;88:999–1003.
O’Hara MA, Anderson RT, Brown D. MR imaging in ophthalmoplegic migraine of children. Presented as a poster at the American Association of Pediatric Ophthalmology and Strabismus, Orlando, FL; April 5–9, 1995.
O’Hare AE, Dutton GN, Green D, Coull R. Evolution of a form of pure alexia without agraphia in a child sustaining occipital lobe infarction at 21/2 years. Dev Med Child Neurol. 1998;40:417–20.
Okubo Y, Matsuura M, Asai T, et al. Epileptiform EEG discharges in healthy children: prevalence, emotional and behavioral correlates, and genetic influences. Epilepsia. 1994;35:832–41.
Olbrich H, Engelmeier MP, Pauleikhoff D, Waubke T. Visual hallucinations in ophthalmology. Graefes Arch Clin Exp Ophthalmol. 1987;225:217–20.
Olesen J. Migraine and regional cerebral blood flow. Trends Neurosci. 1985;8:318–21.
Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol. 1981;9:344–52.
Oliver TA, Hoehn ME, Boop F, Ellison DW. Pituitary adenoma causing visual disturbances in a 6-year-old girl. J AAPOS. 2011;15:495–8.
Olness K, MacDonald JT, Uden DL. Comparison of self-hypnosis and propranolol in the treatment of juvenile classic migraine. Pediatrics. 1987;79:593–7.
Ophoff RA, Terwindt GM, Vergouwe MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell. 1996;87:543–52.
Osako M, Harasawa K, Suzuki H, Usui M, Hoshika A. The characteristics of static visual fields in children with psychogenic visual disturbances. Jpn J Ophthalmol. 2000;44:516–9.
O’Sullivan F, Rossor M, Elston JS. Amaurosis fugax in young people. Br J Ophthalmol. 1992;76:660–2.
Ota I, Kuroshima K, Nagaoka T. Fundus video of retinal migraine. JAMA Ophthalmol 2013;131:1481–82. http://archopht.jamanetwork.com/multimediaPlayer.aspx?mediaid=5983454. Accessed 13 Nov 2014.
Pacheva IH, Ivanov IS. Migraine variants: occurrence in pediatric neurology practice. Clin Neurol Neurosurg. 2013;115:1775–83.
Panayiotopoulos CP. Benign childhood epilepsy with occipital paroxysms: a 15-year prospective clinical and electroencephalographic study. Ann Neurol. 1989;26:51–6.
Panayiotopoulos CP. Difficulties in differentiating migraine in epilepsy based on clinical and EEG findings. In: Andermann F, Lugaressi E, editors. Migraine in Epilepsy. Boston: Butterworth; 1987.
Panayiotopoulos CP. Elementary visual hallucinations in migraine and epilepsy. J Neurol Neurosurg Psychiatry. 1994;57:1371–4.
Panayiotopoulos CP. The birth and evolution of the concept of Panayiotopoulos syndrome. Epilepsia. 2007;48:1041–3.
Papetti L, Nicita F, Parisi P, Spalice A, Villa MP, Kasteleijn-Nolst Trenité DG. “Headache and Epilepsy”—how are they connected? Epilepsy Behav. 2013;26:386–93.
Paquier PF, De Smet HJ, Mariën P, Poznanski N, Van Bogaert P. Acquired alexia without agraphia syndrome in childhood. J Child Neurol. 2006;21:324–30.
Parisi P, Pagani J, Galiffa S, Villa MP. Migrainous vertigo unresponsive to antimigraine therapy in a child with “asymptomatic” cerebellar lesion: casual or causal association? Cephalalgia. 2005;25:831–5.
Parisi P, Villa MP, Pelliccia A, Rollo VC, Chiarelli F, Verrotti A. Panayiotopoulos syndrome: diagnosis and management. Neurol Sci. 2007;28:72–9.
Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984;16:481–8.
Peatfield RC, Petty RG, Rose FC. Double blind comparison of mefenamic acid and acetaminophen (paracetamol) in migraine. Cephalalgia. 1983;3:129–34.
Penfield W, Erickson TC. Epilepsy and Cerebral Localization. Springfield: Charles C. Thomas; 1941. p. 101–3.
Penfield W, Kristiansen K. Seizure Patterns. Epileptic Seizure Pattern. Springfield: Charles C. Thomas; 1951. p. 16–84.
Penfield W, Parot P. The brain’s record of auditory and visual experience. Brain. 1963;86:595–696.
Peroutka SJ. Migraine: a chronic sympathetic nervous system disorder. Headache. 2004;44:53–64.
Petzold A, Islam N, Plant GT. Video reconstruction of vasospastic transient monocular blindness. N Engl J Med. 2003;348:1609–10.
Pfaender M, D’Souza WJ, Trost N, Litewka L, Paine M, Cook M. Visual disturbances representing occipital lobe epilepsy in patients with cerebral calcifications and celiac disease: a case series. J Neurol Neurosurg Psychiatry. 2004;75:1623–5.
Pietrobon D, Moskowitz MA. Pathophysiology of migraine. Annu Rev Physiol. 2013;75:365–91.
Pochedly C, Miller SP, Mehta A. “Hypercoagulable state” in children with acute leukemia or disseminated solid tumors. Oncology. 1973;28:517–22.
Ponjavic V, Andréasson S. Multifocal ERG and full-field ERG, in patients on long-term vigabatrin medication. Doc Ophthalmol. 2001;102:63–72.
Porciatti V, Bonanni P, Fiorentini A, Guerrini R. Lack of cortical contrast gain in human photosensitive epilepsy. Nat Neurosci. 2000;3:259–63.
Powers SW, Kashikar-Zuck SM, Allen JR, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA. 2013;310:2622–30.
Prensky AL, Sommer D. Diagnosis and treatment of migraine in children. Neurology. 1979;29:506–10.
Presad S, Boes AD, Leone AP, Caviness VS, Fox MD. Peduncular hallucinosis: a lesion-based network analysis. Presented at the North American Neuro-Ophthalmology Society meeting, March 4, 2014, Rio Grande, Puerto Rico.
Priest JR, Ramsay NK, Bennett AK, Krivit W, Edson JR. The effect of l-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia. J Pediatr. 1982;100:990–5.
Priest JR, Ramsay NK, Latchaw RE, et al. Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia. Cancer. 1980;46:1548–54.
Pui C-H, Jackson CW, Chesney C, et al. Sequential changes in platelet function in coagulation in leukemic children treated with L-asparaginase prednisone of vincristine. J Clin Oncol. 1983;1:380–5.
Purvin V, Selky AK. Palinopsia following LSD ingestion. Presented as a poster at the North American Neuro-ophthalmology Society Meeting. Tucson, AZ; Feb 19–23, 1995.
Rabinowicz IM. Amblyopia. In: Harley RD, editor. Pediatric Ophthalmology, vol. I. 2nd ed. Philadelphia: WB Saunders; 1983. p. 293–348.
Rada RT, Krill AE, Meyer GG, Armstrong D. Visual conversion reaction in children. II. Follow-up. Psychosomatics. 1973;14:271–6.
Rada RT, Meyer GG, Kellner R. Visual conversion reaction in children and adults. J Nerv Ment Dis. 1978;166:580–7.
Rafay MF, Armstrong D, deVeber G, Domi T, Chan A, MacGregor DL. Craniocervical arterial dissection in children: clinical and radiographic presentation and outcome. J Child Neurol. 2006;21:8–16.
Ramadan NM, Tietjen GE, Levine SR, Welch KM. Scintillating scotomata associated with internal carotid artery dissection: report of three cases. Neurology. 1991;41:1084–7.
Ramsay NK, Coccia PF, Krivit W, Nesbit ME, Edson JR. The effect of L-asparaginase on plasma coagulation factors in acute lymphoblastic leukemia. Cancer. 1977;40:1398–401.
Raskin NH, Schwartz RK. Icepick-like pain. Neurology. 1980;30:203–5.
Riedel KG, Zwaan J, Kenyon KR, Kolodny EH, Hanninen L, Albert DM. Ocular abnormalities in mucolipidosis IV. Am J Ophthalmol. 1985;99(2):125–36.
Rho JM, Chugani HT. Alternating hemiplegia of childhood: insights into its pathophysiology. J Child Neurol. 1998;13:39–45.
Riant F, Ducros A, Ploton C, Barbance C, Depienne C, Tournier-Lasserve E. De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine. Neurology. 2010;75:967–72.
Riaz G, Selhorst JB, Hennessey JJ. Meningeal lesions mimicking migraine. Neuro-Ophthalmology. 1991;11:41–8.
Riela AR, Roach ES. Etiology of stroke in children. J Child Neurol. 1993;8:201–20.
Rinalduzzi S, Valeriani M, Vigevano F. Brainstem dysfunction in alternating hemiplegia of childhood: a neurophysiologic study. Cephalalgia. 2006;26:511–9.
Rippe DJ, Edwards MK, Schrodt JF, Bognanno JR, D'Amour PG, Boyko OB. Reversible cerebral lesions associated with tiazofurin usage: MR demonstration. J Comput Assist Tomogr. 1988;12:1078–81.
Robertson Jr WC, Schnitzier ER. Ophthalmoplegic migraine in infancy. Pediatrics. 1978;61:886–8.
Rolak AL, Baram TZ. Visual hallucinations: more diagnosis. JAMA. 1987;257:2036. Letter.
Romanello S, Spiri D, Marcuzzi E, et al. Association between childhood migraine and history of infantile colic. JAMA. 2013;309:1607–12.
Rosewich H, Ohlenbusch A, Huppke P, et al. The expanding clinical and genetic spectrum of ATP1A3-related disorders. Neurology. 2014;82:945–55.
Rossi LN, Penzien JM, Deonna T, Goutières F, Vassella F. Does migraine-related stroke occur in childhood? Dev Med Child Neurol. 1990;32:1016–21.
Rossi LN, Vassella F. Headache in children with brain tumors. Childs Nerv Syst. 1989;5:307–9.
Rotenstreich Y, Fishman GA, Anderson RJ. Visual acuity loss and clinical observations in a large series of patients with Stargardt disease. Ophthalmology. 2003;110(6):1151–8.
Rothner AD, Pirikh S. Migraine variants or episodic syndromes that may be associated with migraine and other unusual pediatric headache syndromes. Headache. 2016;56:206–14.
Rotstein M, Doran J, Yang H, Ullner PM, Engelstad K, De Vivo DC. Glut1 deficiency and alternating hemiplegia of childhood. Neurology. 2009;73:2042–4.
Rummelt V, Folberg R, Ionasescu V, Yi H, Moore KC. Ocular pathology of MELAS syndrome with mitochondrial DNA nucleotide 3243 point mutation. Ophthalmology. 1993;100:1757–66.
Russell MB, Iselius L, Olesen J. Migraine without aura and migraine with aura are inherited disorders. Cephalalgia. 1996;16:305–9.
Russell WR, Whitty CWM. Studies in traumatic epilepsy. 3: visual fits. J Neurol Neurosurg Psychiatry. 1955;18:79–96.
Rüther K, Pung T, Kellner U, Schmitz B, Hartmann C, Seeliger M. Electrophysiologic evaluation of patients with peripheral visual field contraction associated with vigabatrin. Arch Ophthalmol. 1998;116:817–9.
Sadeh M, Goldhammer Y, Kuritsky A. Postictal blindness in adults. J Neurol Neurosurg Psychiatry. 1983;46:566–9.
Sadun AA, Currie JN, Lessell S. Transient visual obscurations with elevated optic discs. Ann Neurol. 1984;16:489–94.
Saidkasimova S, Bennett DM, Butler S, Dutton GN. Cognitive visual impairment with good visual acuity in children with posterior periventricular white matter injury. A series of 7 cases. J AAPOS. 2007;11:426–30.
Salanova V, Andermann F, Olivier A, Rasmussen T, Quesney LF. Occipital lobe epilepsy: electroclinical manifestations, electrocorticography, cortical stimulation and outcome in 42 patients treated between 1930 and 1991. Brain. 1992;115:1655–80.
Sánchez-Albisua I-S, Schöning M, Jurkat-Rott K, Lerch H. Possible effect of corticoids on hemiplegic attacks in severe hemiplegic migraine. Pediatr Neurol. 2013;49:286–8.
Sanguineti B, Crovato F, De Marchi R, Desirello G. “Alice in Wonderland” syndrome in a patient with infectious mononucleosis. J Infect Dis. 1983;147:782.
Sanner G, Bergström B. Benign paroxysmal torticollis in infancy. Acta Paediatr Scand. 1979;68:219–23.
Santhouse AM, Howard RJ, Ffytche DH. Visual hallucinatory syndromes and the anatomy of the visual brain. Brain. 2000;123:2055–64.
Santos CH, Almeida IL, Gomes MD, et al. Bilateral occipital calcification, epilepsy and celiac disease: case report [Article in Portuguese.]. Arq Neuropsiquiatr. 2002;60:840–3.
Sasaki M, Ishii A, Saito Y, et al. Genotype-phenotype correlations in alternating hemiplegia of childhood. Neurology. 2014;82:482–90.
Savitsky N, Tarachow S. Lilliputian hallucinations during convalescence of scarlet fever. J Nerv Ment Dis. 1941;93:310–2.
Sawamura H, Yamamoto T, Ohtomo R, Bannai T, Wakakura M, Tsuji S. Anti-NMDA receptor encephalitis associated with transient cerebral dyschromatopsia, prosopagnosia, and lack of stereopsis. J Neuroophthalmol. 2014;34:144–8.
Saygi S, Alehan F, Erol I, Yalcın YY, Ataç FB, Kubat G. TGF-β1 genotype in pediatric migraine patients. J Child Neurol. 2014, in press.
Schankin CJ, Maniyer FH, Digre KB, Goadsby PJ. ‘Visual snow’—a disorder distinct from persistent migraine aura. Brain. 2014;137:1419–24.
Schankin CJ, Naniyer FH, Sprenger T, Chou DE, Eller M, Goadsby PJ. The relation between migraine, typical migraine aura and “visual snow.” Headache. 2014;54:957–66.
Schlaegel Jr TF, Quilala FV. Hysterical amblyopia. Arch Ophthalmol. 1955;54:875–84.
Schreier HA, Libow JA. Munchausen by proxy syndrome: a modern pediatric challenge. J Pediatr. 1994;125:S110–5.
Schwartz TL, Vahgei L. Charles Bonnet syndrome in children. J AAPOS. 1998;2:310–3.
Scott JA, Egan RA. Prevalence of organic neuro-ophthalmologic disease in patients with functional visual loss. Am J Ophthalmol. 2003;135:670–5.
Scully R, Mark E, McNeely W, et al. Case Records of the Massachusetts General Hospital. Case 39–1998—a 13-year-old girl with a relapsing-remitting neurological disorder. N Engl J Med. 1998;339:1914–23.
Selby G. Migraine and Its Variants. Sydney: Adis Health Science Press; 1983. p. 33.
Selby G, Lance JW. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry. 1960;23:23–32.
Selhorst JB, Saul RF, Waybright EA. Optic nerve conduction: opposing effects of exercise and hyperventilation. Trans Am Neurol Assoc. 1981;106:101–5.
Seybold ME, Rosen PN. Peripapillary staphyloma and amaurosis fugax. Ann Ophthalmol. 1977;9:1139–41.
Shaikh S, Trese MT. New insights into progressive visual loss in adult retinopathy of prematurity. Arch Ophthalmol. 2004;122:404–6.
Shams PN, Plant GT. Migraine-like visual aura due to focal cerebral lesions: case series and review. Surv Ophthalmol. 2011;56:135–61.
Shepherd AJ. Colour vision in migraine: selective deficits for S-cone discriminations. Cephalalgia. 2005;25:412–23.
Shutter LA, Green JP, Newman NJ, Hooks MA, Gordon RD. Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation. Neurology. 1993;43:2417–8.
Silberstein S, Lenz R. Therapeutic monoclonal antibodies: What headache specialists need to know. Headache. 2015;55:1171–82.
Simpson JC, Goadsby PJ, Prabhakar P. Positive persistent visual symptoms (visual snow) presenting as a migraine variant in a 12-year-old girl. Pediatr Neurol. 2013;49:361–3.
Singhi S, Jacobs H, Gladstein J. Pediatric headache: where have we been and where do we need to be. Headache. 2014;54:817–29.
Sitko KR, Peragallo JH, Bidot S, et al. Pitfalls in the use of stereoacuity in the diagnosis of organic visual loss. Ophthalmology. 2016;123:198–202.
Smith TJ, Baker RS. Perimetric findings in functional disorders using automated techniques. Ophthalmology. 1987;94:1562–6.
Snebold NG, Rizzo JF, Lessell S, et al. Transient visual loss in ornithine transcarbamoylase deficiency. Am J Ophthalmol. 1987;104:407–12.
Solomon GD. Migrainous periorbital ecchymosis. Headache. 1989;29:328. Abstract.
Somerville BW. Treatment of migraine attacks with an analgesic combination (Mersyndol). Med J Aust. 1976;1:865–6.
Song H, Rossi EA, Latchney L, et al. Cone and rod loss in Stargardt disease revealed by adaptive optics scanning light ophthalmoscopy. JAMA Ophthalmol. 2015, in press.
Sørensen JB, Parnas J. A clinical study of 44 patients with juvenile amaurotic familial idiocy. Acta Psychiatr Scand. 1979;59:449–61.
Sprenger T, Magon S. Can functional magnetic resonance imaging at rest shed light on the pathophysiology of migraine? Headache. 2013;53:723–5.
Steg RE, Garcia EG. Complex visual hallucinations and cyclosporine neurotoxicity. Neurology. 1991;141:1156.
Steinberg H. Erythropoietin and visual hallucinations. N Engl J Med. 1991;325:285.
Stellingwerf C. Charles Bonnet Syndrome in Children. Vilamoura: European Paediatric Ophthalmological Society; 2006.
Stommel JE, Ward TN, Harris RD. MRI findings in a case of ophthalmoplegic migraine. Headache. 1993;33:234–7.
Stone J, La France WC, Levenson Jr JL, Sharpe M. Issues for DSM-5: conversion disorder. Am J Psychiatry. 2010;167:626–7.
Stone EM, Nichols BE, Kimura AE, Weingeist TA, Drack A, Sheffield VC. Clinical features of a Stargardt-like dominant progressive macular dystrophy with genetic linkage to chromosome 6q. Arch Ophthalmol. 1994;112:765–72.
Strauss H. Paroxysmal blindness. Electroencephalogr Clin Neurophysiol. 1963;15:921. Abstract.
Strupp M, Zwergal A, Brandt T. Episodic ataxia type 2. Neurotherapeutics. 2007;4:267–73.
Swainman KF, Frank Y. Seizure headaches in children. Dev Med Child Neurol. 1978;20:580–5.
Taich A, Crowe S, Kosmorsky GS, Traboulsi EI. Prevalence of psychosocial disturbances in children with nonorganic visual loss. J AAPOS. 2004;8:457–61.
Takano T, Tian G-F, Peng W, et al. Cortical spreading depression causes and coincides with tissue hypoxia. Nat Neurosci. 2007;10:754–62.
Tamhankar MA, Coslett HB, Fisher MJ, Sutton LN, Liu GT. Alexia without agraphia following biopsy of a left thalamic tumor. Pediatr Neurol. 2004;30:140–2.
Tandon A, Branson HM, Buncic JR. Transient visual loss and isolated disk edema in juvenile nasopharyngeal angiofibroma. J AAPOS. 2010;14:90–2.
Tarantino S, Capuano A, Torriero R, et al. Migraine equivalents as part of migraine syndrome in childhood. Pediatr Neurol. 2014;51:645–9.
Tasman W, Brown GC. Progressive visual loss in adults with retinopathy of prematurity (ROP). Trans Am Ophthalmol Soc. 1988;86:367–79.
Taylor D, Avetisov ES. Pediatric Ophthalmology. Boston: Blackwell Publications; 1990. p. 568–9.
Terwindt GM, Ophoff RA, van Eijk R, et al. Involvement of the CACNA1A gene containing region on 19p13 in migraine with and without aura. Neurology. 2001;56:1028–32.
Tfelt-Hansen P, Olesen J. Effervescent metoclopramide and aspirin (Migraves) versus effervescent aspirin or placebo for migraine attacks: a double-blind study. Cephalalgia. 1984;4:107–11.
Thompson HS. Functional visual loss. Am J Ophthalmol. 1985;100:209–13.
Thomsen LL, Ostergaard E, Olesen J, Russell MB. Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology. 2003;60:595–601.
Tietjen GE. Migraine as a systemic disorder. Neurology. 2007;68:1555–6.
Tippin J, Corbett JJ, Kerber RE, Schroeder E, Thompson HS. Amaurosis fugax and ocular infarction in adolescents and young adults. Ann Neurol. 1989;26:69–77.
Todd J. The syndrome of Alice in Wonderland. Can Med Assoc J. 1955;73:701–4.
Toldo I, Pinello L, Suppiej A, et al. Nonorganic (psychogenic) visual loss in children: a retrospective series. J Neuroophthalmol. 2010;30:26–30.
Tomsak RL, Jergens PB. Benign recurrent transient monocular blindness: a possible variant of acephalgic migraine. Headache. 1987;27:66–9.
Törnqvist G. Paralysis of accommodation. Acta Ophthalmol (Copenh). 1971;49:702–6.
Troost BT, Mark LE, Maroon JC. Resolution of classic migraine after removal of an occipital lobe AVM. Ann Neurol. 1979;5:199–201.
Troost BT, Newton TH. Occipital lobe arteriovenous malformations: clinical and radiological features in 26 cases with comments on differentiation from migraine. Arch Ophthalmol. 1975;93:250–65.
Tsao C-Y. Cerebellar ataxia, vertical supranuclear gaze palsy, sensorineural deafness, epilepsy, dementia, and hallucinations in an adolescent male. Semin Pediatr Neurol. 2014;21:106–8.
Uliss AE, Moore AT, Bird AC. The dark choroid in posterior retinal dystrophies. Ophthalmology. 1987;94:1423–7.
Underwood E. A shot at migraine. Science. 2016;351:116–9.
Uneri A, Turkdogan D. Evaluation of vestibular functions in children with vertigo attacks. Arch Dis Child. 2003;88:510–1.
van Balen AT, Slijper FE. Psychogenic amblyopia in children. J Pediatr Ophthalmol Strabismus. 1978;15(3):164–7.
van Bogaert L. L’hallucinose pedunculaire. Rev Neurol. 1927;43:608–17.
van de Ven RCG, Kaja S, Plomp JJ, Frants RR, van den Maagdenberg AMJM, Ferrari MD. Genetic models of migraine. Arch Neurol. 2007;64:643–6.
van Gelder P, Geurs P, Kho GS, Dippel DW, Vecht CJ, Splinter TA. Cortical blindness and seizures following cisplatin treatment: both of epileptic origin? Eur J Cancer. 1993;29A:1497–8.
van Harreveld A. The nature of the chick’s magnesium sensitive retinal spreading depression. J Neurobiol. 1984;15:333–44.
Van Harreveld A. Two mechanisms for spreading depression in the chicken retina. J Neurobiol. 1978;6:419–31.
Van Lith GHM. General cone dysfunction without achromatopsia. In: Pearlman JT, editor. 10th ISCERG symposium—color vision deficiencies. XII. Amsterdam: Kluwer Academic Publishers; 1995. p. 203–10.
Vanmolkot FH, Van Bortel LM, de Hoon JN. Altered arterial function in migraine of recent onset. Neurology. 2007;68:1563–70.
Velentgas P, Cole JA, Mo J, Sikes CR, Walker AM. Severe vascular events in migraine patients. Headache. 2004;44:642–51.
Vijayan N. Ophthalmoplegic migraine: ischemic or compressive neuropathy? Headache. 1980;20:300–4.
Vike J, Jabbari B, Maitland CG. Auditory-visual synesthesia: report of a case with intact visual pathways. Arch Neurol. 1984;41:680–1.
von Brevern M, Zeise D, Neuheuser H, Clarke AH, Lempert T. Acute migrainous vertigo: clinical and oculographic findings. Brain. 2005;128:365–74.
von Noorden GK. Idiopathic amblyopia. Am J Ophthalmol. 1985;100:214–7.
Walsh JP, O’Doherty DS. A possible explanation of the mechanism of ophthalmoplegic migraine. Neurology. 1960;10:1079–84.
Wang J, Spencer R, Leffler JN, Birch EE. Characteristics of peripapillary retinal nerve fiber layer in preterm children. Am J Ophthalmol. 2012;153:850–5.
Warrell RP, Berman E. Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity. J Clin Oncol. 1986;4:76–9.
Waxman SG. Clinical course and electrophysiology of multiple sclerosis. In: Waxman SG, editor. Functional Recovery in Neurological Disease. New York: Raven Press; 1988. p. 157–84.
Weiller C, May A, Limmroth V, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med. 1995;1:658–60.
Weinberger LM, Grant FC. Visual hallucinations and their neuro-optical correlates. Arch Ophthalmol. 1940;23:166–99.
Welch KMA. Drug therapy of migraine. N Engl J Med. 1993;329:1476–83.
Welch KM, Barkley GL, Tepley N, Ramadan NM. Central neurogenic mechanisms of migraine. Neurology. 1993;43 Suppl 3:S21–5.
Welch KM, D’Andrea G, Tepley N, et al. The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin. 1990;8:817–28.
Weleber RG. Stargardt’s macular dystrophy. Arch Ophthalmol. 1994;112:752–4.
Weleber RG, Carr RE, Murphey WH, Sheffield VC, Stone EM. Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene. Arch Ophthalmol. 1993;11:1531–42.
Weleber RG, Shults WT. Digoxin retinal toxicity. Clinical and electrophysiological evaluation of a cone dysfunction syndrome. Arch Ophthalmol. 1981;99:1568–72.
Weller CM, Leen WG, Neville BGR, et al. A novel SLC2A1 mutation linking hemiplegic migraine with alternating hemiplegia of childhood. Cephalagia. 2014, in press.
Weller CM, Pelzer N, de Vries B, et al. Two novel SCN1A mutations identified in families with familial hemiplegic migraine. Cephalalgia. 2014;34:1062–9.
Weller M, Wiedemann P. Visual hallucinations. An outline of etiological and pathogenetic concepts. Int Ophthalmol. 1989;13:193–9.
Wertenbaker C, Gutman I. Unusual visual symptoms. Surv Ophthalmol. 1985;29:297–9.
Wessman M, Kallela M, Kaunisto MA, et al. A susceptibility locus for migraine with aura, on chromosome 4q24. Am J Hum Genet. 2002;70:652–62.
White CP, Jan JE. Visual hallucinations after acute visual loss in a young child. Dev Med Child Neurol. 1992;34:259–61.
Williamson DJ, Hargreaves RJ, Hill RG, Shepheard SL. Intravital microscope studies on the effects of neurokinin agonists and calcitonin gene-related peptide on dural blood vessel diameter in the anaesthetized rat. Cephalalgia. 1997;17:518–24.
Williamson PD, Boone PA, Spencer DD, et al. Occipital and parietal epilepsy. Epilepsy. 1988;29:682.
Williamson PD, Thadani VM, Darcy TM, Spencer DD, Spencer SS, Mattson RH. Occipital lobe epilepsy: clinical characteristics, seizure spread patterns, and results of surgery. Ann Neurol. 1992;31:3–13.
Winterkorn JM. “Retinal Migraine” is an oxymoron. J Neuroophthalmol. 2007;27:1–2.
Winterkorn JM. Vasospasm or migraine? Presented at the American Academy of Ophthalmology, San Francisco; November 1994.
Winterkorn JM, Burde RM. Vasospasm—not migraine—in the anterior visual pathway. Ophthalmol Clin North Am. 1996;9:393–405.
Winterkorn J, Kupersmith MJ, Wirtschafter JD, Forman S. Treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med. 1993;329:396–8.
Wirrell EC, Hamiwka LD, Hamiwka LA, Grisaru S, Wei X. Acute glomerulonephritis presenting with PRES: a report of 4 cases. Can J Neurol Sci. 2007;34:316–21.
Wisotsky BJ, Engel HM. Transesophageal echocardiography in the diagnosis of branch retinal artery obstruction. Am J Ophthalmol. 1993;115:653–6.
Wolff HG. Headache and Other Head Pain. 2nd ed. New York: Oxford University Press; 1963.
Woods RP, Iacoboni M, Mazziotta JC. Bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med. 1994;331:1689–92.
Wraith E. Ornithine carbamoyltransferase deficiency. Arch Dis Child. 2001;84:84–8.
Wright Jr JD, Boger 3rd WP. Visual complaints from healthy children. Surv Ophthalmol. 1999;44:113–21.
Wu W-C, Lin R-I, Shih C-P. Visual acuity, optical components, and macular abnormalities in patients with a history of retinopathy of prematurity. Ophthalmology. 2012;119:1907–16.
Wunderlich G, Suchan B, Volkmann J, Herzog H, Hömberg V, Seitz RJ. Visual hallucinations in recovery from cortical blindness: imaging correlates. Arch Neurol. 2000;57:561–5.
Wynick S, Hobson RP, Jones RB. Psychogenic disorders of vision in childhood (“visual conversion reactions”): perspectives from adolescence: a research note. J Child Psychol Psychiatry. 1997;38:375–9.
Yasuna ER. Hysterical amblyopia in children. Am J Dis Child. 1963;106:558–63.
Xi Q, Li L, Traboulsi EI, Wang QK. Novel ABCA4 compound heterozygous mutations cause severe progressive autosomal recessive cone-rod dystrophy presenting as Stargardt disease. Mol Vis. 2009;15:638–45.
Yanni SE, Wang J, Chan M, et al. Foveal avascular zone and foveal pit formation after preterm birth. Br J Ophthalmol. 2012;96:961–6.
Yenice Ö, Onal S, Incili B, Temel A, Afşar N, Tanridağ T. Assessment of spatial-contrast function and short-wavelength sensitivity deficits in patients with migraine. Eye. 2007;21:218–23.
Yorns Jr WR, Hardison HH. Mitochondrial dysfunction in migraine. Semin Pediatr Neurol. 2013;20:188–93.
Younkin D. Topirate in the treatment of pediatric migraine. Headache. 2002;42:456. Abstract.
Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitichondrial optic neuropathies—disease mechanisms and therapeutic strategies. Prog Retin Eye Res. 2011;30:81–114.
Zemen W, Donahue S, Dyken P, et al. The neuronal ceroid lipofuscinosis (Batten-Vogt syndrome). In: Vinken PJ, Bruyn GW, editors. Leukodystrophies and Polio Dystrophies. Handbook of Clinical Neurology, vol. 10. New York: American Elsevier; 1970. p. 588–679.
Zenker G, Erbel R, Krämer G, et al. Transesophageal two-dimensional echocardiography in young patients with cerebral ischemic events. Stroke. 1988;19:345–8.
Zhang K, Bither PP, Park R, Donoso LA, Seidman JG, Seidman CE. A dominant Stargardt’s macular dystrophy locus maps to chromosome 13q34. Arch Ophthalmol. 1994;112:759–64.
Ziegler DK, Hurwitz A, Hassanein RS, Kodanaz HA, Preskorn SH, Mason J. Migraine prophylaxis: a comparison of propranolol and amitriptyline. Arch Neurol. 1987;44:486–9.
Zung A, Margalith D. Ictal cortical blindness: a case report and review of the literature. Dev Med Child Neurol. 1993;35:921–6.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science + Business Media New York
About this chapter
Cite this chapter
Brodsky, M.C. (2016). Transient, Unexplained, and Psychogenic Visual Loss in Children. In: Pediatric Neuro-Ophthalmology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3384-6_5
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3384-6_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-3382-2
Online ISBN: 978-1-4939-3384-6
eBook Packages: MedicineMedicine (R0)